Presentation from the University of Strathclyde at the Centre for Defence Enterprise Marketplace held on 27 April

1. Professor Terence Gourlay
Head of Department of Biomedical Engineering,
University of Strathclyde
Marketplace 2016

2. University of Strathclyde
Our Department of Biomedical Engineering is ranked
1st in the UK for Medical Technology Teaching in the
2016 Complete University Guide.
We carry out research in medical device development,
cell and tissue engineering, medical diagnostics,
surgical robotics and rehabilitation engineering.
What we do

3. Development of a portable blood salvage and auto-transfusion
technology to enhance survivability of personnel requiring
major medical interventions
Uncontrolled haemorrhage is the leading
cause of death on the battlefield.
We modified hemosep©- our commercial
clinical device for blood salvage and
autotransfusion – to provide urgent haemostatic
resuscitation to enhance survivability of injured
military personnel.
Clinical hemosep
Field-deployable autotransfusion system
Pump
Processing
Bag
Transfusion bag
Collection
Bag
Suction
wand
Anticoagulation drip
This technology required:
- portability for battlefield administration
- performance without need for power
- rapid haemoconcentration and autotransfusion

4. Success to date
Low flow pump transports
collected blood into processing
bag for haemoconcentration
High flow
pump to
evacuate
blood from
wound
Hand crank
Gear box
increases
output flow
CAD Design 3D Printed Prototyping
Compatibility with electronic screwdriver
Plug & play motorised docking station to
use core system in military treatment facility
Optimisation to enhance user experience
SPARGER:
Blood
collection
bag with
integrated
filter and
defoamer
Advanced HemoSep membrane technology
for rapid blood concentration
Pump technology to collect
blood for autotransfusion and
haemoconcentration

5. What next?
Effectiveness proven in the laboratory setting.
Clinical and field testing is essential before
the device can be taken on its regulatory and
commercial journey.
This technology is based on a highly
successful civilian hospital technology. We
anticipate that this new, portable technology
will considerably enhance survivability of
casualties with severe haemorrhage in the
battlefield and civil disaster settings through
the provision of auto-transfusion and cell
concentration, reducing the need for donor
blood products and associated logistics.

6. We’re looking for…
What are you looking for from the Marketplace audience?
We ‘ve already established a commercial partner to take the
technology beyond the prototype stage. However, we need
clinical support and input to the technology with a view to
engaging in clinical trials.
Where do you want to take the technology?
With the support of our commercial partners, after clinical trails
and the regulator pathway are complete, we wish to deliver
this technology to the UK military medical sector and beyond.

7. Contact
Contact details:
terence.gourlay@strath.ac.uk